2025-520996-16-00CompletedPhase 1/2
A single-center pilot study to establish a novel hypoglycemic clamp procedure to assess the time to spontaneous recovery from hypoglycemia in people with and without diabetes
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Jun 2025
Brief summary (registry, in English)
To describe the relationship in the insulin dose required to lower plasma glucose (PG) from 90 – 70 mg/dL versus lowering PG from 70 – 48 mg/dL
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 12 Mar 2025
- Start date
- 2 Jul 2025
- Lead sponsor
- Medical University Of Graz
- Diseases
- Type 2 diabetes
- EU CT number
- 2025-520996-16-00
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 24
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Age in the registry: 18 years to 64 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Graz | Graz | Austria | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.